Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-02 Sale |
2025-04-03 4:21 pm |
Arcutis Biotherapeutics Inc. | ARQT | Topper David Joseph Chief Financial Officer |
9,600 | $15.8 | $151,698 | 182,774 (Direct) |
View |
| 2024-09-24 Sale |
2024-09-25 9:42 pm |
Arcutis Biotherapeutics Inc. | ARQT | Topper David Joseph Chief Financial Officer |
11,626 | $9.4843 | $110,264 | 158,374 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-28 Option Award |
2025-03-04 7:43 pm |
N/A 2035-02-28 |
Arcutis Biotherapeutics Inc. | ARQT | Topper David Joseph Chief Financial Officer |
123,000 | $0 | 281,374 (Direct) |
View |
| 2024-09-21 Option Award |
2024-09-25 9:42 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Topper David Joseph Chief Financial Officer |
60,000 | $0 | 158,374 (Direct) |
View |
| 2024-04-10 Option Award |
2024-04-11 8:32 pm |
N/A 2034-04-10 |
Arcutis Biotherapeutics Inc. | ARQT | Topper David Joseph Chief Financial Officer |
420,000 | $0 | 420,000 (Direct) |
View |
Ownership |
2024-04-11 8:30 pm |
N/A 2033-12-18 |
Arcutis Biotherapeutics Inc. | ARQT | Topper David Joseph Chief Financial Officer |
0 | $0 | 7,500 (Direct) |
View |
| 2022-11-22 Exercise |
2022-11-23 4:31 pm |
N/A N/A |
Frazier Lifesciences Acquisition Corp | FLAC | Topper David Joseph Chief Financial Officer |
30,000 | $0 | 0 (Direct) |
View |
Ownership(A) |
2020-12-17 4:07 pm |
N/A N/A |
Frazier Lifesciences Acquisition Corp | FLAC | Topper David Joseph Chief Financial Officer |
0 | $0 | 30,000 (Direct) |
View |
Ownership |
2020-12-08 5:33 pm |
N/A N/A |
Frazier Lifesciences Acquisition Corp | FLAC | Topper David Joseph Chief Financial Officer |
0 | $0 | 25,000 (Direct) |
View |